Salivary Duct Carcinoma

• CLINICAL_TRIALS research · 2025-09-23
  Clinical Trial Update: Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma [Phase 2]

  Phase 2 adjuvant trial evaluating Rezvilutamide with androgen deprivation therapy in AR-positive, high-risk salivary duct carcinoma. The stu…

• CLINICAL_TRIALS research · 2025-06-04
  Clinical Trial Update: Phase II Dutasteride in Combination With CAB vs CAB in SDC [Phase 2]

  Phase II clinical trial evaluating dutasteride in combination with a CAB regimen versus CAB alone in salivary duct carcinoma; currently recr…

• CLINICAL_TRIALS trial_result · 2025-02-17
  Clinical Trial Update: P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) [Phase 1]

  Poseida Therapeutics conducted a Phase 1 trial of P-PSMA-101 CAR-T cells in metastatic castration-resistant prostate cancer and advanced sal…

• CLINICAL_TRIALS trial_result · 2023-05-10
  Clinical Trial Update: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients [Phase 2]

  Phase 2 clinical trial evaluating Lutetium-177-PSMA radioligand therapy for advanced salivary gland cancers has completed.

• CLINICAL_TRIALS trial_result · 2022-01-04
  Clinical Trial Update: Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma [Phase 2]

  Phase 2 trial update for the combination of Nanoxel and Herzuma in salivary duct carcinoma is in early phases with unknown status.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2018-05-30
  Clinical Trial Update: PSMA-PET Imaging for Advanced ACC/SDC [NA]

  This entry notes the completion of a clinical trial evaluating PSMA-PET imaging in advanced adenoid cystic carcinoma and salivary duct carci…